John T Curnutte
CIK 1574589 · EVP R&D · last filed 2025-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
41
Lifetime Open-Market Net
-$7.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLRX | Director | — | $1.13 | — | $0 | 5 | 2025-06-09 |
| Orchard Therapeutics plc (ORTX) Delisted | Director | — | $16.70 | — | $0 | 5 | 2024-01-24 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | EVP R&D | 102,559 | — | — | -$7.83M | 30 | 2019-05-21 |
Recent Filings · Page 5 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-03-27 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 41–41 of 41
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.